Carbon dioxide (CO2) laser treatment is a common therapeutic modality for many dermatologic conditions. It uses a high energy, infrared beam of light, which selectively targets water-containing tissue resulting in controlled ablative resurfacing. This modality, however, can manifest significant cosmetic side effects. Here we report a case of verruca plana manifesting as a response to CO2 laser treatment. A 74-year-old female with recent Mohs surgery for a basal cell carcinoma, presented for full-face-fractionated CO2 treatment to address her surgical scars in addition to treating her mild diffuse actinic damage. Six weeks post treatment, the patient developed erythematous thin plaques over the areas that had been treated. Histology was consistent with verruca plana. Lesions showed mild improvement with topical tretinoin. Verruca plana are benign and typically self-limited; however, they can present a significant cosmetic burden to patients and are an important complication to consider when performing elective cosmetic procedures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/14764172.2014.983932 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lactococcus lactis Strain Plasma for the Treatment of Verruca Plana Juvenilis.
Am J Ther
July 2024
Division of Dermatology, Tsuruse Orthopedic Clinic, Saitama, Japan.
Article Synopsis
- Acrokeratosis verruciformis of Hopf (AKVH) is a rare genetic skin disorder characterized by mutations affecting keratinization, leading to symmetric, flat lesions primarily seen in childhood but can appear atypically in adults.
- It often mimics other skin conditions, making histopathological examination crucial for accurate diagnosis, especially in areas with limited resources.
- The first reported case from North-East India highlights the effectiveness of cryotherapy combined with acitretin in treating AKVH, showing quick improvement in a patient whose symptoms resembled extensive verruca vulgaris.
Tazarotene is as effective and well-tolerated as imiquimod in the treatment of verruca plana: a comparative randomized controlled trial.
Clin Exp Dermatol
September 2024
Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Egypt.
Background: Plane warts, when multiple and recurrent, present a therapeutic challenge acting as a source of reinfection, causing frustration and affecting a patient's quality of life. For large numbers of lesions in cosmetically significant sites, topical treatment is preferred to avoid potential sequelae.
Objectives: To evaluate and compare the efficacy and tolerability of tazarotene 0.
Resolution of extensive plantar verruca vulgaris but not facial verruca plana following nonavalent human papillomavirus vaccine: A case report and literature review.
J Dermatol
August 2024
Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Comparative study on the age-related incidence of seborrheic keratosis and verruca plana in patients with verruca plana-like lesions.
Sci Rep
March 2024
Department of Dermatology, Ajou University School of Medicine, Suwon, South Korea.
Seborrheic keratosis (SK) is a common skin disease in the elderly. However, in cases where SK presenting as multiple skin-colored or clustered lesions can be easily misdiagnosed as verruca plana (VP), especially in the young population. This retrospective study investigated the prevalence of SK and VP in the lesions that appear clinically similar to VP according to age.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!